Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation
Douglas D. Fraser(Western University), Michael R. Miller(Western University), Gediminas Cepinskas(Western University), David B. O’Gorman(Western University), Claudio M. Martin(Western University), Marat Slessarev(Western University), Mark Daley(Western University), Sean E. Gill(Western University), David E. Carter(Western University), Eric K. Patterson(Lawson Health Research Institute), Claúdia C. dos Santos(St. Michael's Hospital)
Cited by 66
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597